Tuesday, 16 November , 2021 · 14:00 - 15:30 CET · Online
The World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, and major surgery will become too dangerous to perform.
In the Pharmaceutical Strategy for Europe, the European Commission declared that “new business models are required” if we are to meet this challenge and succeed, spotlighting 2022 as the year when change needs to happen.
Join us to discuss how we can drive investment in antimicrobials R&D and set out a roadmap to a sustainable innovation ecosystem that will safeguard society against the threat of AMR.
With thanks from the organisers, an EFPIA initiative, in collaboration with Reuters Events.
Mark Jones Head of Preclinical Development and Clinical Project Management Basilea Board Member BEAM Alliance & Swiss Round Table for Antibiotics Alliance
Velina Pendolovska Deputy Head of Unit of the Health Security Unit of Directorate-General Health and Food Safety (DG SANTE) European Commission
Read BioMary Lynne Van Poelgeest President World Federation of Incontinence and Pelvic Problems (WFIPP)
Read Bio09:00am – 09:30am
Welcome remarks
MODERATOR: Fiona Walker Health Journalist
09:00am – 09:30am
The patient perspective: Advocating in the fight against AMR
Mary Lynne Van Poelgeest President World Federation of Incontinence and Pelvic Problems (WFIPP)
Juan Jose Fernandez Romero Policy Assistant European Patients Forum (EPF)
09:00am – 09:30am
FIRESIDE CHAT: A new EU pull incentive to address AMR
Tim Wilsdon Vice President, Life Sciences CRA
09:00am – 09:30am
PANEL: 2022 and beyond: Let’s find the solutions to support R&D of new antimicrobials
Mark Jones Head of Preclinical Development and Clinical Project Management Basilea Board Member BEAM Alliance & Swiss Round Table for Antibiotics Alliance
Prof. Kevin Outterson Professor and Executive Director CARB-X
Kristine Peers General Counsel EFPIA
Dr. Henry Skinner CEO AMR Action Fund
Velina Pendolovska Deputy Head of Unit of the Health Security Unit of Directorate-General Health and Food Safety (DG SANTE) European Commission
Get in touch with the Reuters Events team